Skip to content

COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY

COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04367896
Enrollment
1819
Registered
2020-04-29
Start date
2020-03-24
Completion date
2020-04-17
Last updated
2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION

Keywords

COVID-19, Solid Organ Transplantation

Brief summary

Background COVID-19 has brought into questioning the equitable distribution of resources. Solid Organ Transplants (SOT) are life-saving procedures. Rapid changes in the management of patients are occurring, with potential for inequity. Drawing on professionals across transplant specialities, we investigated resource distribution specifically for SOT to guide healthcare policies. A multidisciplinary team developed a survey. The survey included demographic questions to contextualise respondents, questions on resource allocation for SOT. Multiple strategies were used to distribute the survey internationally. Descriptive, uni-multivariate ordinal regressions analysis were performed. Open comments were analysed using qualitative methods.

Interventions

OTHERSurvey Group

The survey sought to elucidate equity principles that are influencing transplant decision making. The group of respondents included solid organ transplant doctors (surgeons, referring doctors, transplant physicians, transplant coordinators, ICU transplant doctors), COVID-doctors (ICU doctors, Infectious Disease Doctors, Pulmonologists, Internists), and Ethicists with experience of transplant related issues. Respondent identification: A. The e-mail addresses of corresponding authors from Scopus January 1, 2017 and march 20, 2020: All (surgery) AND subj (medi) and key (transplantation), All (critical care) AND subj (medi) and key (transplantation), All (ethics) AND subj (medi) and key (transplantation). B. Emailing through the mailing list of scientific societies. C. The link to the survey published online. D. The link to the survey circulated through personal contacts and via social media sites.

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Inclusion criteria

* transplant surgeons, referring doctors, transplant physicians, transplant coordinators, transplant ICU doctors, COVID-19 ICU, Infectious Disease Doctors, Pulmonologists, Internist, and Ethicists

Exclusion criteria

* not applicable

Design outcomes

Primary

MeasureTime frameDescription
Management of Solid Organ Transplant during COVID-19 pandemic20/04/2020Question 1Given the COVID-19 outbreak, should liver transplant activities be stopped? with three possible answers (Completely, Selectively and Not at All)
Equity of resource distribution20/04/2020Question 2I feel that the current policy to allocate most resources to COVID-19 meets the equity of access in healthcare for different diseases with four possible alternative answers (strongly agree, partially agree, partially disagree and strongly disagree).

Secondary

MeasureTime frameDescription
Equity rank of resource distribution20/04/2020Scale (10 strongly agree- 0 strongly disagree).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026